Extracellular Volume and Fibrosis Volume of Left Ventricular Myocardium Assessed by Cardiac Magnetic Resonance in Vaccinated and Unvaccinated Patients with a History of SARS-CoV-2 Infection

Overview

Journal Cardiovasc Toxicol

Specialties Cardiology & Vascular Diseases
Toxicology

Date 2024 Oct 15

PMID 39404974

Authors

Pawel Gac

Wojciech Hajdusianek

Aleksandra Zorawik

Malgorzata Poreba

Rafal Poreba

Affiliations

Soon will be listed here.

Abstract

Cardiac magnetic resonance (CMR) enables the assessment of tissue characteristics of the myocardium. Changes in the extracellular volume (ECV) and fibrosis volume (FV) of the myocardium are sensitive and early pathogenetic markers and have prognostic significance. The aim of the study was to assess ECV and FV of left ventricular myocardium in T1 mapping sequence in patients with a history of SARS-CoV-2 infection, considering vaccination status against COVID-19. The study group consisted of 97 patients (52.54 ± 8.31 years, 53% women and 47% men). The participants were divided into three subgroups: A) patients with a history of symptomatic SARS-CoV-2 infection, unvaccinated against COVID-19 (n = 39), B) patients with a history of symptomatic SARS-CoV-2 infection, with a full vaccination schedule against COVID-19 (n = 22), and C) persons without a history of SARS-CoV-2 infection constituting the control subgroup (C, n = 36). All patients underwent 1.5 T cardiac magnetic resonance. In subgroup A compared to subgroups B and C, both the ECV whole myocardium and ECV segments 2, 5-6, 8, and 10-11 were statistically significantly higher. In addition, the ECV segment 16 was statistically significantly higher in subgroup A than in subgroup C. Also, the FV whole myocardium was statistically significantly higher in subgroup A in comparison to subgroups B and C. There were no significant differences in ECV and FV between subgroups B and C. In summary, unvaccinated against COVID-19 patients with a history of symptomatic SARS-CoV-2 infection have higher myocardial ECV and FV values in the T1 mapping sequence, compared to those without COVID-19 and those suffering from COVID-19, previously vaccinated with the full vaccination schedule.

References

Li X, Wang H, Zhao R, Wang T, Zhu Y, Qian Y . Elevated Extracellular Volume Fraction and Reduced Global Longitudinal Strains in Participants Recovered from COVID-19 without Clinical Cardiac Findings. Radiology. 2021; 299(2):E230-E240. PMC: 7808090. DOI: 10.1148/radiol.2021203998. View

Bing R, Dweck M . Myocardial fibrosis: why image, how to image and clinical implications. Heart. 2019; 105(23):1832-1840. PMC: 6900237. DOI: 10.1136/heartjnl-2019-315560. View

Puntmann V, Peker E, Chandrashekhar Y, Nagel E . T1 Mapping in Characterizing Myocardial Disease: A Comprehensive Review. Circ Res. 2016; 119(2):277-99. DOI: 10.1161/CIRCRESAHA.116.307974. View

Ture H, Kim N, Nam E . New-onset retroperitoneal fibrosis following COVID-19 mRNA vaccination: Coincidental or vaccine-induced phenomenon?. Int J Rheum Dis. 2023; 26(7):1368-1372. DOI: 10.1111/1756-185X.14621. View

Cerqueira M, Weissman N, Dilsizian V, Jacobs A, Kaul S, Laskey W . Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002; 105(4):539-42. DOI: 10.1161/hc0402.102975. View

Miller C, Naish J, Bishop P, Coutts G, Clark D, Zhao S . Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013; 6(3):373-83. DOI: 10.1161/CIRCIMAGING.112.000192. View

Messroghli D, Moon J, Ferreira V, Grosse-Wortmann L, He T, Kellman P . Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular.... J Cardiovasc Magn Reson. 2017; 19(1):75. PMC: 5633041. DOI: 10.1186/s12968-017-0389-8. View

Treibel T, White S, Moon J . Myocardial Tissue Characterization: Histological and Pathophysiological Correlation. Curr Cardiovasc Imaging Rep. 2014; 7(3):9254. PMC: 4169521. DOI: 10.1007/s12410-013-9254-9. View

Liang J, Li H, Xie J, Yu H, Chen W, Yin K . Iodine-based extracellular volume for evaluating myocardial status in patients undergoing percutaneous coronary intervention for acute myocardial infarction by using dual-layer spectral detector computed tomography: a comparison study with magnetic.... Quant Imaging Med Surg. 2022; 12(9):4502-4511. PMC: 9403598. DOI: 10.21037/qims-21-1103. View

10.

Kim H, Jenista E, Wendell D, Azevedo C, Campbell M, Darty S . Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. JAMA Cardiol. 2021; 6(10):1196-1201. PMC: 8243258. DOI: 10.1001/jamacardio.2021.2828. View

11.

Barreiro-Perez M, Pastor Pueyo P, Raposeiras-Roubin S, Montero Corominas D, Uribarri A, Eiros Bachiller R . Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management. Rev Esp Cardiol (Engl Ed). 2023; 76(7):555-563. PMC: 10008093. DOI: 10.1016/j.rec.2023.01.011. View

12.

Fries R, Kadotani S, Keating S, Stack J . Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy. J Vet Intern Med. 2021; 35(2):812-822. PMC: 7995366. DOI: 10.1111/jvim.16067. View

13.

Xu J, Zhuang B, Sirajuddin A, Li S, Huang J, Yin G . MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction. Radiology. 2019; 294(2):275-286. PMC: 6996717. DOI: 10.1148/radiol.2019190651. View

14.

Schelbert E, Piehler K, Zareba K, Moon J, Ugander M, Messroghli D . Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage. J Am Heart Assoc. 2015; 4(12). PMC: 4845263. DOI: 10.1161/JAHA.115.002613. View

15.

Moon J, Messroghli D, Kellman P, Piechnik S, Robson M, Ugander M . Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013; 15:92. PMC: 3854458. DOI: 10.1186/1532-429X-15-92. View

16.

John B, Deng Y, Schwartz K, Taddei T, Kaplan D, Martin P . Postvaccination COVID-19 infection is associated with reduced mortality in patients with cirrhosis. Hepatology. 2022; 76(1):126-138. PMC: 9015228. DOI: 10.1002/hep.32337. View

17.

Haaf P, Garg P, Messroghli D, Broadbent D, Greenwood J, Plein S . Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson. 2016; 18(1):89. PMC: 5129251. DOI: 10.1186/s12968-016-0308-4. View

18.

Wong T, Piehler K, Meier C, Testa S, Klock A, Aneizi A . Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation. 2012; 126(10):1206-16. PMC: 3464491. DOI: 10.1161/CIRCULATIONAHA.111.089409. View

19.

Markousis-Mavrogenis G, Bacopoulou F, Vlachakis D, Mavrogeni S . Tissue Characterization in Cardiology: Moving Beyond Function. Adv Exp Med Biol. 2022; 1337:89-97. DOI: 10.1007/978-3-030-78771-4_11. View

20.

Knudsen B, Prasad V . COVID-19 vaccine induced myocarditis in young males: A systematic review. Eur J Clin Invest. 2022; 53(4):e13947. PMC: 9880674. DOI: 10.1111/eci.13947. View